BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 155 filers reported holding BLUEBIRD BIO INC in Q2 2022. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $81 | -79.5% | 63,579 | -51.1% | 0.00% | -100.0% |
Q3 2023 | $395 | +6.2% | 130,097 | +15.0% | 0.00% | +33.3% |
Q2 2023 | $372 | -85.2% | 113,093 | -68.8% | 0.00% | -91.4% |
Q4 2022 | $2,508 | -99.9% | 362,544 | -54.6% | 0.04% | -2.8% |
Q2 2022 | $3,303,000 | +486.7% | 798,048 | +4170.6% | 0.04% | +500.0% |
Q1 2021 | $563,000 | +17.8% | 18,687 | +396.3% | 0.01% | -80.0% |
Q2 2019 | $478,000 | +46.2% | 3,765 | +81.0% | 0.03% | -41.2% |
Q1 2019 | $327,000 | – | 2,080 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 82,500 | $5,090,000 | 4.20% |
RTW INVESTMENTS, LP | 122,576 | $7,563,000 | 2.85% |
Eventide Asset Management | 587,677 | $36,260,000 | 2.36% |
First Light Asset Management, LLC | 71,246 | $4,396,000 | 1.93% |
ARK Investment Management | 75,645 | $4,667,000 | 1.70% |
Taylor Wealth Management Partners | 39,118 | $2,414,000 | 1.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 302,027 | $18,635,000 | 0.77% |
ARMISTICE CAPITAL, LLC | 40,000 | $2,468,000 | 0.58% |
Artal Group S.A. | 422,536 | $26,070,000 | 0.58% |
Baillie Gifford | 5,164,467 | $318,647,000 | 0.52% |